2,533
Views
4
CrossRef citations to date
0
Altmetric
ISV Annual Congress SF – Commentary

Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer’s perspective

&
Article: 2050123 | Received 20 Dec 2021, Accepted 03 Mar 2022, Published online: 31 Mar 2022

Figures & data

Figure 1. Vaxxas’ HD-MAP, one of several vaccine MAPs under development worldwide. (a) the circular 1 cm2 MAP; (b) Close-up of the array of ~1,700 micro-projections; (c) scanning electron micrograph of vaccine-coated projections; (d) Vaxxas’ integrated HD-MAP and applicator;. The vaccine-coated HD-MAP is contained within the device, under the foil seal. the units nest together for convenient transport and storage, potentially outside the vaccine cold chain.

Figure 1. Vaxxas’ HD-MAP, one of several vaccine MAPs under development worldwide. (a) the circular 1 cm2 MAP; (b) Close-up of the array of ~1,700 micro-projections; (c) scanning electron micrograph of vaccine-coated projections; (d) Vaxxas’ integrated HD-MAP and applicator;. The vaccine-coated HD-MAP is contained within the device, under the foil seal. the units nest together for convenient transport and storage, potentially outside the vaccine cold chain.

Figure 2. Application of the HD-MAP, in this case to the forearm, which could be by self-administration.

Figure 2. Application of the HD-MAP, in this case to the forearm, which could be by self-administration.